scispace - formally typeset
M

Mitchell S. Nobler

Researcher at Columbia University

Publications -  52
Citations -  3914

Mitchell S. Nobler is an academic researcher from Columbia University. The author has contributed to research in topics: Electroconvulsive therapy & Dysthymic Disorder. The author has an hindex of 28, co-authored 52 publications receiving 3732 citations. Previous affiliations of Mitchell S. Nobler include New Generation University College & New York Medical College.

Papers
More filters
Journal ArticleDOI

A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.

TL;DR: Right unilateral ECT at high dosage is as effective as a robust form of BL ECT, but produces less severe and persistent cognitive effects.
Journal ArticleDOI

Effects of Pulse Width and Electrode Placement on the Efficacy and Cognitive Effects of Electroconvulsive Therapy

TL;DR: The use of an ultrabrief stimulus markedly reduces adverse cognitive effects, and when coupled with markedly suprathreshold right unilateral ECT, also preserves efficacy.
Journal ArticleDOI

Decreased Regional Brain Metabolism After ECT

TL;DR: Widespread regions of decreased regional cerebral glucose metabolism were identified after ECT, especially in the frontal and parietal cortex, anterior and posterior cingulate gyrus, and left temporal cortex.
Journal ArticleDOI

Regional Cerebral Blood Flow in Mood Disorders, III: Treatment and Clinical Response

TL;DR: The findings indicated that cerebral blood flow abnormalities in major depression were not reversed by successful treatment with ECT, rather, particularly in responders, ECT resulted in additional perfusion reductions.
Journal ArticleDOI

EEG manifestations during ECT : effects of electrode placement and stimulus intensity

TL;DR: It is found that specific features of the ictal and immediate postictal EEG varied significantly with ECT stimulus intensity and electrode placement, and this indicates that seizure duration is not a useful marker of therapeutic efficacy, and provides preliminary evidence that other features ofThe EEG may be more useful markers of treatment adequacy.